5 Questions For MedImmune's Jallal On Right Culture And Staying Open To Collaboration
This article was originally published in Scrip
Executive Summary
Scrip caught up with Dr. Bahija Jallal, AstraZeneca's executive vice president and head of subsidiary MedImmune, at BIO Europe 2015, in Munich, Germany, to discuss challenges ahead for pharma and biotech firms, how business models are evolving to focus on culture not just size and why collaboration is the gateway to innovation.